亚洲 · 区域市场 · Pulse (Maeil Business)
SK Bioscience Q3 revenue rises 21%, operating loss narrows
SK Bioscience reported a 21 percent increase in third-quarter revenue Thursday, driven by growth at its German contract manufacturing subsidiary and stronger vaccine sales, while…
在 Pulse (Maeil Business) 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (pulse.mk.co.kr)
